<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03356938</url>
  </required_header>
  <id_info>
    <org_study_id>CHPNP2016</org_study_id>
    <nct_id>NCT03356938</nct_id>
  </id_info>
  <brief_title>The Role of the Circadian System in Neurological Sleep-wake Disorders</brief_title>
  <acronym>PNP</acronym>
  <official_title>The Role of the Circadian System in Neurological Sleep-wake Disorders: Assessment of Circadian and Homeostatic Sleep-wake Regulation and Vigilance With a Poly-nap Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Esther Werth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the role of the circadian system in patients with
      neurologic sleep-wake disorders. Therefore, overnight sleep will be distributed over 30 hours
      into repetitive sleep-wake cycles (poly-nap protocol), so that sleep episodes occur at
      different circadian phases. Vigilance, attention, risk behavior as well as sleep onset
      latency will be observed.

      Ambulatory accelerometer recordings gain more and more attention in the diagnostic work-up of
      sleep disorders, as they allow to also include the everyday rest-activity rhythm before
      examinations in the sleep laboratory. Advances of novel devices should improve the detection
      of rest and activity and therefore the estimation of sleep and wake, especially in patients
      with neurologic sleep-wake disorders exhibiting fragmented sleep. Two types of actimeters
      will be applied throughout our study protocol to explore better classification of sleep and
      wake phases and patterns of the rest-activity rhythm.

      This study is designed as an observational case-controlled study targeting the disorders of
      narcolepsy type 1 and idiopathic hypersomnia, and including interventional procedures in the
      healthy control group (sleep deprivation, sleep restriction) in a counter-balanced design.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endogenous melatonin</measure>
    <time_frame>Half an hour before and half an hour after a nap during PNP protocol, up to 2 minutes.</time_frame>
    <description>Dim light melatonin onset (DLMO) will show whether there is a phase difference between patient groups and between patients and controls. The amplitude of the melatonin profile will show whether there is a dampening of the circadian rhythm or not.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EEG slow-wave activity (SWA)</measure>
    <time_frame>Over nap times, up to 80 minutes.</time_frame>
    <description>SWA is a marker of homeostatic sleep pressure and will show whether patients with narcolepsy or idiopathic hypersomnia live under different sleep pressure than controls.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance in neurobehavioral tests</measure>
    <time_frame>One hour before each nap, up to 45mins.</time_frame>
    <description>Outcome for vigilance and cognition of the subjects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EEG event related potentials (ERPs)</measure>
    <time_frame>One hour before each nap, up to 45minutes.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Narcolepsy 1</condition>
  <condition>Idiopathic Hypersomnia</condition>
  <arm_group>
    <arm_group_label>Baseline recording</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleep restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleep deprivation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep restriction</intervention_name>
    <description>Restricted sleep to 5 hours / night for 5 days prior to sleep laboratory examination</description>
    <arm_group_label>Sleep restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep deprivation</intervention_name>
    <description>Sleep deprivation during first night of sleep laboratory examination</description>
    <arm_group_label>Sleep deprivation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Female participants 18 years to 35 years of age

          -  Written informed consent by the participant after information about the research
             project

          -  Healthy controls: 7-8 hours of sleep per night

          -  Healthy controls: sleep satiation before start of the study

          -  Narcolepsy type 1: diagnosis of narcolepsy with cataplexy, drug free during study,
             proven excessive daytime sleepiness with increased REM (MSLT), clear-cut cataplexy
             present, undetectable or low cerebrospinal fluid hypocretin levels (if data is
             available)

          -  Idiopathic hypersomnia: diagnosis of idiopathic hypersomnia, drug free during study,
             proven excessive daytime sleepiness without increased REM (MSLT), increased sleep need
             (&gt;10h/day) on work-free days shown by 2-week actigraphy

        Exclusion Criteria:

          -  signs of neurological, psychiatric, or other sleep-wake disorders

          -  signs of sleep deprivation

          -  shift work and time zone change of more than one hour within one month prior the study
             start

          -  extreme morning and evening types

          -  underweight

          -  obstructive gastro-intestinal disease or history of gastrointestinal surgery

          -  an implanted medical device or a scheduled MRI scan during the experimental period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Werth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esther Werth, PhD</last_name>
    <phone>0041 44 255 55 35</phone>
    <email>esther.werth@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Franziska Ryser, MSc.</last_name>
    <phone>0041 44 255 10 43</phone>
    <email>franziska.ryser@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Werth, PhD</last_name>
      <phone>+41-(0)44-255-5535</phone>
      <email>esther.werth@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Franziska Ryser, MSc.</last_name>
      <phone>+41-(0)44-255-1043</phone>
      <email>franziska.ryser@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Borbély AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1(3):195-204.</citation>
    <PMID>7185792</PMID>
  </reference>
  <reference>
    <citation>Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007 Feb 10;369(9560):499-511. Review.</citation>
    <PMID>17292770</PMID>
  </reference>
  <reference>
    <citation>Frenette E, Kushida CA. Primary hypersomnias of central origin. Semin Neurol. 2009 Sep;29(4):354-67. doi: 10.1055/s-0029-1237114. Epub 2009 Sep 9. Review.</citation>
    <PMID>19742411</PMID>
  </reference>
  <reference>
    <citation>Münch M, Knoblauch V, Blatter K, Schröder C, Schnitzler C, Kräuchi K, Wirz-Justice A, Cajochen C. Age-related attenuation of the evening circadian arousal signal in humans. Neurobiol Aging. 2005 Oct;26(9):1307-19. Epub 2005 Apr 18.</citation>
    <PMID>16182904</PMID>
  </reference>
  <reference>
    <citation>Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005 Oct 27;437(7063):1257-63. Review.</citation>
    <PMID>16251950</PMID>
  </reference>
  <reference>
    <citation>Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010 Aug;11(8):589-99. doi: 10.1038/nrn2868. Epub 2010 Jul 14. Review.</citation>
    <PMID>20631712</PMID>
  </reference>
  <reference>
    <citation>Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ; Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007 Apr;30(4):519-29.</citation>
    <PMID>17520797</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Esther Werth</investigator_full_name>
    <investigator_title>Head of Sleep Laboratory</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Narcolepsy</mesh_term>
    <mesh_term>Disorders of Excessive Somnolence</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Hypersomnolence, Idiopathic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

